atinvicitinib (Numelvi)

Structure

• see

Indications

• investigational treatment of atopic dermatitis in dogs

Dosage

• 4.8 mg, 7,2 mg, 21.6 mg, 31.6 mg oral tablets

Mechanism of action

• selective Janus kinase (JAK) inhibitor
  • highly selective for Janus kinase 1 (JAK1)

More general terms

• Janus kinase inhibitor; JAK inhibitor

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=135138184